ArticlePloS one2021
Influenza vaccination hesitancy in large urban centers in South America. Qualitative analysis of confidence, complacency and convenience across risk groups.
Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 30 citations in OpenAlex.
- Factors influencing vaccine uptake during pregnancy: A systematic literature review.Human vaccines & immunotherapeutics · 2026Pooled it
- Barriers and facilitators to vaccination in Latin America: a thematic synthesis of qualitative studies.Cadernos de saude publica · 2024Pooled it
- Impact of influenza, herpes zoster, and pneumococcal vaccinations on the incidence of cardiovascular events in subjects aged over 65 years: a systematic review.GeroScience · 2023Pooled it
- Impact of social media use on influenza vaccine hesitancy among pediatric healthcare workers: The mediating role of 3Cs.Human vaccines & immunotherapeutics · 2026Article
- Drivers and barriers to influenza vaccination in the post-COVID-19 era in the Federation of Bosnia and Herzegovina: A qualitative study using focus groups with risk groups and in-depth interviews with physicians.Human vaccines & immunotherapeutics · 2026Article
- Knowledge, attitudes and practices about dengue vaccines in Latin America and the Caribbean: a scoping review.Cadernos de saude publica · 2026Article
- Respiratory Vaccines in Older Adults: A Bibliometric Analysis and Future Research Agenda.Vaccines · 2025Review
- Factors associated with HPV vaccine hesitancy among college students: A cross-sectional survey based on 3Cs and structural equation model in China.Human vaccines & immunotherapeutics · 2024Article
- Article
- [Evaluation of the scenario of hesitancy in vaccines against seasonal influenza among public school teachers in Teresina, Piauí State, Brazil, in COVID-19 times].Cadernos de saude publica · 2024Article
- Prevalence of immunization against influenza in elderly Brazilians: National Health Survey, 2019.Revista da Associacao Medica Brasileira (1992) · 2024Article
- COVID-19 vaccine booster dose hesitancy among key groups: A cross-sectional study.Human vaccines & immunotherapeutics · 2023Article
- Socio-demographic determinants of influenza vaccination uptake behavior: A nationwide cross-sectional study in Saudi Arabia.Saudi medical journal · 2023Article
- COVID-19 Vaccine Hesitancy Among Patients Recovered From COVID-19 Infection in Wuhan, China: Cross-Sectional Questionnaire Study.JMIR public health and surveillance · 2023Article
- Healthcare Workers' Attitudes toward Influenza Vaccination: A Behaviour and Social Drivers Survey.Vaccines · 2023Article
- Knowledge, attitudes, perceptions, and practice toward seasonal influenza and its vaccine: A cross-sectional study from a country of conflict.Frontiers in public health · 2023Article
- Determinants of Covid-19 vaccine uptake among the elderly aged 58 years and above in Kericho County, Kenya: Institution based cross sectional survey.PLOS global public health · 2023Article
- Explorative study regarding influenza vaccine hesitancy among HIV-infected patients.Human vaccines & immunotherapeutics · 2022Article
- Models of determinants of COVID-19 vaccine hesitancy in non-pregnant and pregnant population: Review of current literature".Human vaccines & immunotherapeutics · 2022Review
- Psychometric validation of a chinese version of COVID-19 vaccine hesitancy scale: a cross-sectional study.BMC infectious diseases · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 7 institutions in 6 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Influenza vaccination coverage in countries of Latin America is low among priority risk groups, ranging from 5 to 75% among older people. This paper aims to describe and analyze the determinants of influenza vaccination hesitancy through the lens of the 3C model of confidence, complacency and convenience among middle-class, urban risk group populations in Brazil, Chile, Paraguay, Peru, Uruguay, countries in South America with contrasting vaccination coverage. Focus groups were conducted among four risk groups: pregnant women, mothers of children aged <6 years, adults with risk factors, and adults aged ≥60 years in samples of urban residents. Adults with risk factors expressed the most detailed perceptions about confidence in the vaccine. A wide range of perceptions regarding complacency were expressed across risk groups and countries, with pregnant women and mothers showing greater concerns while convenience had a narrower and generally more positive range of perceptions. Participants from Chile and Paraguay expressed the most contrasts regarding confidence and complacency. Information and communication strategies need to be tailored for risk groups while confidence and complacency should be addressed in synergy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.